ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
FTSE 100
8,786.46
0.06%
Dow Jones
41,860.44
-1.91%
Gold vs US Dollar
3,321.635
0.93%
Brent Oil
64.23
-1.34%
Bitcoin
109,691.44
2.70%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
22/05/202500:55PR Newswire (US)TSA prepares for busy Memorial Day holiday travel
22/05/202500:30PR Newswire (US)Mercury Insurance and LA Kings Celebrate Ordinary People with Extraordinary Impact
22/05/202500:16PR Newswire (US)ABUSE OCCURRED AT EIGHTY-ONE PERCENT OF THE ARCHDIOCESE OF SAN FRANCISCO'S PARISHES
22/05/202500:15UK RegulatoryPress Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipelineTG:SNWSanofi
22/05/202500:15UK RegulatoryCommuniqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologieTG:SNWSanofi
22/05/202500:15UK RegulatoryCommuniqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologieEU:SANSanofi
22/05/202500:15UK RegulatoryCommuniqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologieBIT:SANFSanofi
22/05/202500:15UK RegulatoryCommuniqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologieBIT:1SANSanofi
22/05/202500:15UK RegulatoryPress Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipelineBIT:1SANSanofi
22/05/202500:15UK RegulatoryPress Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipelineBIT:SANFSanofi
22/05/202500:15UK RegulatoryPress Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipelineEU:SANSanofi
22/05/202500:05Alliance NewsAlliance NewsUK consumer sentiment improves in May on boost from trade deals - BRC
22/05/202500:04Alliance NewsAlliance NewsUK new job postings up in April despite rise in costs, says REC
22/05/202500:00PR Newswire (US)Cracker Barrel Elects Steve Bramlage to Board of DirectorsNASDAQ:CBRLCracker Barrel Old Country Store Inc
22/05/202500:00PR Newswire (US)Mercy Medical Center's "WE ARE 150" Anniversary Campaign Wins 2025 TELLY Award
22/05/202500:00PR Newswire (US)Cracker Barrel Elects Steve Bramlage to Board of DirectorsNASDAQ:CASYCaseys General Stores Inc
21/05/202523:43PR Newswire (US)Frankenmuth Insurance Appoints Chief Legal Officer and Corporate Secretary
21/05/202523:36PR Newswire (US)TAT Technologies Expands MRO Partnership with Leading International Cargo Carrier; APU maintenance for Boeing 737, 757, 767, and Airbus A300 fleetsNASDAQ:TATTTAT Technologies Ltd
21/05/202523:35PR Newswire (US)OMRON Healthcare Evolves the Blood Pressuring Experience with AI-powered AFib detection
21/05/202523:27PR Newswire (US)/C O R R E C T I O N -- UpdatePromise/
21/05/202523:14PR Newswire (US)INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Paramount Group, Inc. to Contact Law FirmNYSE:PGREParamount Group Inc
21/05/202523:02PR Newswire (US)Diverse, High-Impact Board Elected to Guide Next Phase of Growth for TucowsTSX:TCTucows Inc
21/05/202523:02PR Newswire (US)Diverse, High-Impact Board Elected to Guide Next Phase of Growth for TucowsNASDAQ:TCXTucows Inc
21/05/202523:00PR Newswire (US)New Found Gold Continues to Expand the Dropkick Zone at the Queensway Gold Project: 42.8 g/t Au over 14.95 m, 47.6 g/t Au over 3.95 m and 22.9 g/t Au over 2.40 mAMEX:NFGCNew Found Gold Corporation
21/05/202523:00PR Newswire (US)Greenberg Traurig Lawyers Recognized in Inaugural Lawdragon 500 Leading Global Tax Lawyers Guide
21/05/202523:00PR Newswire (US)Vaughn College Celebrates the Class of 2025 at its 93rd Commencement Ceremony
21/05/202523:00PR Newswire (US)Weyerhaeuser to Sell Princeton, B.C., Lumber Mill to Gorman GroupNYSE:WYWeyerhaeuser Company
21/05/202522:58PR Newswire (US)Seaboard Corporation Announces a $100 million Share Repurchase ProgramAMEX:SEBSeaboard Corp
21/05/202522:49PR Newswire (US)Elbit Systems Announces Underwritten Public Offering of 1,365,450 SharesNASDAQ:ESLTElbit Systems Ltd
21/05/202522:31PR Newswire (US)Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory Approval | DelveInsight

Your Recent History

LSE
PANR
Pantheon Resources
LSE
SBTX
Skinbiotherapeutics
LSE
POS
Plexus
LSE
BIRD
Blackbird
LSE
TERN
Tern
LSE
NEXN
Nexxen
LSE
GKP
Gulf Keystone Petroleum
LSE
QBT
Quantum Blockchain Techn...
LSE
AGL
Angle
LSE
GGP
Greatland Gold
LSE
THG
Thg
LSE
MKS
Marks And Spencer
LSE
CAML
Central Asia Metals
LSE
KEFI
Kefi Gold And Copper
LSE
JLP
Jubilee Metals
LSE
ITM
Itm Power
Delayed Upgrade Clock
    ADVFN Logo
    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads